|
MEIS3P1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.45554704242568E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.23879994940302E-09 |
| Normal-vs-Stage2 |
3.62440000000186E-05 |
| Normal-vs-Stage3 |
2.13099538015626E-11 |
| Normal-vs-Stage4 |
8.43769498715119E-15 |
| Stage1-vs-Stage2 |
4.856400E-01 |
| Stage1-vs-Stage3 |
3.176500E-02 |
| Stage1-vs-Stage4 |
7.33519999962517E-07 |
| Stage2-vs-Stage3 |
2.532300E-02 |
| Stage2-vs-Stage4 |
1.60985999999586E-05 |
| Stage3-vs-Stage4 |
1.302490E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72439840184779E-11 |
| Normal-vs-AfricanAmerican |
2.13579999999158E-05 |
| Normal-vs-Asian |
5.96909999206474E-09 |
| Caucasian-vs-AfricanAmerican |
6.244800E-01 |
| Caucasian-vs-Asian |
3.898200E-01 |
| AfricanAmerican-vs-Asian |
9.728200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.01899616417245E-11 |
| Normal-vs-Female |
5.9625970827426E-11 |
| Male-vs-Female |
4.210000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.42099998013646E-09 |
| Normal-vs-Age(41-60Yrs) |
4.08129974260873E-10 |
| Normal-vs-Age(61-80Yrs) |
2.65549804367993E-11 |
| Normal-vs-Age(81-100Yrs) |
3.279000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.488200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.071600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.971400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.351600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.860000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.200400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.89821999999618E-05 |
| Classical-VS-Follicular |
6.027400E-01 |
| Classical-VS-Other |
3.035200E-01 |
| Classical-VS-Normal |
2.11260009486125E-10 |
| Tall-VS-Follicular |
9.79079999999799E-05 |
| Tall-VS-Other |
5.618000E-01 |
| Tall-VS-Normal |
4.34874358745674E-13 |
| Follicular-VS-Other |
3.004000E-01 |
| Follicular-VS-Normal |
3.34349999997485E-06 |
| Other-VS-Normal |
1.901560E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.50979997790313E-09 |
| Normal-vs-N1 |
4.62169968962201E-10 |
| N0-vs-N1 |
2.616200E-02 |
|
|
